Halofuginone, (-)-

HCID 400772CAS 55837-20-2
부분 구조 검색유사 구조 찾기

기본 정보

표준 SMILES
O=C(C[C@@H]1NCCC[C@H]1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O
InChIKey
LVASCWIMLIKXLA-LSDHHAIUSA-N
분자식
C16H17BrClN3O3
평균 분자량
414.7 g/mol
단동위원소 질량
413.01418118

이름 및 식별자

우선 이름
Halofuginone, (-)-
IUPAC
7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one

이름 및 동의어

(-)-Halofuginone7695-84-3Halofuginone, (-)-6-Chloro-7-bromofebrifugineNVY6A324PU7-Bromo-6-chloro-3-(3-((2S,3R)-3-hydroxy-2-piperidinyl)-2-oxopropyl)-4(3H)-quinazolinoneDTXSID301339439RefChem:922712DTXCID4017690557-bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one7-bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one.7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one
이름 더 보기
7-bromo-6-chloro-3-{3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl}-3,4-dihydroquinazolin-4-oneHalofuginone (INN)4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-((2S,3R)-3-hydroxy-2-piperidinyl)-2-oxopropyl)-MFCD098341434(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-7-Bromo-6-chloro-3-{3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-oneUNII-NVY6A324PUHalocur [veterinary] (TN)

데이터베이스 식별자

CAS
55837-20-2、7695-84-3
PubChem CID
400772
DTXSID
DTXSID0048260
ChEMBL
CHEMBL1199539
UNII
NVY6A324PU
Nikkaji
J238.338A

물성

구조 계산 물성

XLogP
1.4
극성 표면적
82 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
5
회전 가능 결합 수
4
무거운 원자 수
24

실험 및 물리화학적 성질

Animal Drugs · 2건

Pharmaceuticals -> UK Veterinary Medicines Directorate List

Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

화학 및 산업

약리 정보

MeSH Pharmacological Classification · 4건

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals.

Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins.

Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.

용도 및 제조

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

연결된 노트

불러오는 중…